• Users Online: 884
  • Print this page
  • Email this page
Year : 2022  |  Volume : 11  |  Issue : 1  |  Page : 43-46

A study of clinicoradiological profile in cases of allergic bronchopulmonary aspergillosis

Department of Respiratory Medicine, AMC MET Medical College, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Savita Jindal
A-12 Orchid Greens Girdhar Nagar Circle, Shahibaug, Ahmedabad
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijrc.ijrc_73_21

Rights and Permissions

Introduction: Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic pulmonary disorder caused by a complex hypersensitivity response to inhaled fungal antigens. ABPA occurs most commonly in immunocompetent patients and complicates 1% to 2% of cases of persistent asthma and 7% to 14% of cases of chronic steroid-dependent asthma. Aim: The aim of this study was to study the clinical and radiological profile of patients and to study the serological correlation of ABPA. Methodology: This was a retrospective study done over 6 months from June 2020 to December 2020. Patients who were confirmed cases of ABPA according to the International Society for Human and Animal Mycology criteria were enrolled for the study. Patients' demographic data, pathological, and radiological test results were collected and analyzed. Pre- and post-bronchodilator spirometry of the patients were examined and asthma control was calculated. Results: In the present study, 23 patients were studied. Most patients were young, the mean age was 35.7 years with a female predominance of 56.5%. The most common symptom was cough in 91.3% of patients. All patients had bronchial asthma as a predisposing factor. The mean absolute eosinophil count and mean serum immunoglobulin E were 534 cells/μL and 2270 UI/ml, respectively. About 82.6% of participants in the study had spirometry suggestive of obstructive pattern. Bronchiectasis and parenchymal opacities were the most common radiological abnormality seen. Conclusion: The diagnosis of ABPA must be considered when treating difficult to control asthma. A delay in diagnosis can lead to decreased asthma control, worsening of lung function, sometimes leading to irreversible changes, poor quality of life, and increased cost of treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded69    
    Comments [Add]    

Recommend this journal